Abstract
This paper replaces the 2019 WHO position paper on pneumococcal conjugate vaccine (PCV) use in infants and children aged <5 years. The recommendations for PCV use were made by SAGE at its March 2025 meeting. The evidence reviewed at this meeting, along with SAGE’s most recent declaration of interest assessment, is available at: https://www.who.int/news-room/events/ detail/2025/03/10/default-calendar/strategic-advisory-group-of-experts-on-immunization-march-2025.
Position paper
Pneumococcal disease
